The all-cash transaction is expected to expand Amgen’s presence in Turkey and the surrounding region.
The acquisition was initially announced on 25 April 2012.
MN Pharmaceuticals, a manufacturer of injectable products, was established in 1923 in a district of Istanbul known as Uskudar, Ihsaniye under the name of Mustafa Nevzat Laboratory.
Amgen, a biotechnology company, discovers, develops, manufactures and delivers human therapeutics.